MV Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,035
Closed -$537K 372
2020
Q1
$537K Buy
3,035
+265
+10% +$49.9K 0.14% 59
2019
Q4
$530K Buy
2,770
+267
+11% +$48.2K 0.11% 73
2019
Q3
$421K Buy
2,503
+150
+6% +$24.4K 0.1% 78
2019
Q2
$394K Buy
2,353
+362
+18% +$50.1K 0.09% 79
2019
Q1
$292K Buy
+1,991
New +$289K 0.07% 83
2018
Q4
Sell
-451
Closed -$86K 359
2018
Q3
$86K Sell
451
-11
-2% -$2.02K 0.02% 140
2018
Q2
$77K Buy
462
+14
+3% +$2.25K 0.02% 145
2018
Q1
$75K Sell
448
-11
-2% -$1.84K 0.02% 144
2017
Q4
$75K Buy
459
+27
+6% +$4.84K 0.02% 149
2017
Q3
$89K Sell
432
-46
-10% -$10.7K 0.03% 140
2017
Q2
$116K Sell
478
-90
-16% -$21.1K 0.03% 127
2017
Q1
$136K Sell
568
-11
-2% -$2.56K 0.04% 117
2016
Q4
$122K Sell
579
-64
-10% -$13.3K 0.04% 112
2016
Q3
$148K Sell
643
-94
-13% -$23K 0.05% 104
2016
Q2
$170K Sell
737
-311
-30% -$71.7K 0.06% 101
2016
Q1
$281K Sell
1,048
-228
-18% -$65.3K 0.11% 71
2015
Q4
$399K Buy
1,276
+400
+46% +$119K 0.16% 61
2015
Q3
$238K Buy
876
+105
+14% +$32.3K 0.11% 65
2015
Q2
$234K Buy
771
+169
+28% +$50.4K 0.1% 67
2015
Q1
$179K Buy
602
+478
+385% +$136K 0.07% 77
2014
Q4
$32K Buy
+124
New +$31K 0.01% 196

Other funds holding AGN

MV Capital Management's AGN Position: Q2 2020 in Review

MV Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,035 shares — an estimated $537K sold.

MV Capital Management first reported a position in AGN in Q4 2014 and held it in 21 quarters. The position peaked at $537K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • MV Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • MV Capital Management sold 3,035 Allergan plc shares in Q2 2020, an estimated $537K.
  • MV Capital Management first reported a position in Allergan plc in Q4 2014 and held it in 21 quarters.
  • MV Capital Management's Allergan plc position peaked at $537K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on MV Capital Management's 13F filing for Q2 2020, filed 4 Aug 2020.